Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Addington

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Psychiatric Services (Washington, D.C.)|July 14, 1998
Group treatment for smoking cessation among persons with schizophreniaJ Addington
Nursing Times|April 17, 2002
The end resultsJ Addington-Hall
European Journal of Cancer Care|September 26, 2002
Research sensitivities to palliative care patientsJ Addington-Hall
Acta Psychiatrica Scandinavica|December 12, 1997
Reasons for substance use in schizophreniaJ Addington, V Duchak
Schizophrenia Research|February 28, 1997
Attentional vulnerability indicators in schizophrenia and bipolar disorderJ Addington, D Addington
Psychiatric Rehabilitation Journal|September 1, 2001
Impact of an early psychosis program on substance useJ Addington, D Addington
Acta Psychiatrica Scandinavica|June 15, 2005
Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcomeJ Addington, D Addington
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 16, 1998
Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidolJ Addington, D Addington
Schizophrenia Bulletin|March 31, 1999
Neurocognitive and social functioning in schizophreniaJ Addington, D Addington
Journal of Psychiatry & Neuroscience : JPN|January 1, 1993
Premorbid functioning, cognitive functioning, symptoms and outcome in schizophreniaJ Addington, D Addington
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Psychiatric Services (Washington, D.C.)|July 14, 1998
Group treatment for smoking cessation among persons with schizophreniaJ Addington
Nursing Times|April 17, 2002
The end resultsJ Addington-Hall
European Journal of Cancer Care|September 26, 2002
Research sensitivities to palliative care patientsJ Addington-Hall
Acta Psychiatrica Scandinavica|December 12, 1997
Reasons for substance use in schizophreniaJ Addington, V Duchak
Schizophrenia Research|February 28, 1997
Attentional vulnerability indicators in schizophrenia and bipolar disorderJ Addington, D Addington
Psychiatric Rehabilitation Journal|September 1, 2001
Impact of an early psychosis program on substance useJ Addington, D Addington
Acta Psychiatrica Scandinavica|June 15, 2005
Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcomeJ Addington, D Addington
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 16, 1998
Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidolJ Addington, D Addington
Schizophrenia Bulletin|March 31, 1999
Neurocognitive and social functioning in schizophreniaJ Addington, D Addington
Journal of Psychiatry & Neuroscience : JPN|January 1, 1993
Premorbid functioning, cognitive functioning, symptoms and outcome in schizophreniaJ Addington, D Addington
Pageof 13